01 Increased Adoption in Biotech and Healthcare The global DNA data storage market is experiencing rapid growth, particularly within the biotechnology, pharmaceutical, and healthcare sectors. These industries are increasingly adopting DNA data storage for its potential as a long-term archival solution, especially for vast genetic data, including human genome sequencing and microbial data.As the volume of genetic information expands, the need for durable and scalable storage solutions becomes critical. DNA data storage offers a promising answer due to its exceptional data density and resistance to environmental degradation, making it ideal for storing medical records securely over extended periods. In December 2024, DNA data storage technology saw a breakthrough with the introduction of epi-bit technology. Developed by Zhang et al., this innovation was tested on iDNAdrive, a platform that allows users to encode their own data. Volunteers successfully encoded around 5,000 bits of data using epi-bit writing kits, achieving an impressive error rate of just 1.42% when reading the data. This advancement highlights DNA data storage's growing reliability and potential for various applications in the healthcare and biotech industries.
June 2026 Toregem Biopharma and DNA Data Storage Alliance member Catalog Technologies announced a strategic collaboration to advance DNA synthesis and molecular data storage technologies, supporting scalable commercialization of DNA-based digital storage platforms.
May 2026 Catalog Technologies secured additional strategic funding to accelerate the commercialization of its DNA-based digital data storage platform, expanding R&D and manufacturing capabilities for molecular information storage.
February 2026 Biomemory launched its DNA Cards for commercial archival data storage, introducing one of the first market-ready DNA data storage products designed for ultra-long-term digital preservation.
September 2025 DNA Script expanded its enzymatic DNA synthesis platform through new technology advancements and strategic collaborations, improving the scalability of DNA production for data storage and synthetic biology applications.